Financials
- Market Capitalization 155.7 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
34.53
売上高対価格比率
1.2
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3480 | AKBA Akebia Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -12.50% | -18.95% | -34.75% | 213.37 M USD | ||
| 3629 | DERM Journey Medical Corporation - Common Stock | 5.66 USD | -4.23% | -8.12% | -20.95% | -19.14% | 159.75 M USD | ||
| 3764 | OGI Organigram Global Inc. - Common Shares | 0.92 USD | -1.08% | -5.15% | -12.38% | -35.44% | 123.70 M USD | ||
| 3775 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.19 USD | +0.85% | -9.16% | -39.29% | +17.82% | 119.31 M USD |